Choroidal Neovascularization Market to Register Stunning Growth During the Forecast Period – DelveInsight | Key Companies – Roche, Regeneron, Adverum Biotechnologies, and Iconic Therapeutics

April 27 04:40 2022
Choroidal Neovascularization Market to Register Stunning Growth During the Forecast Period - DelveInsight | Key Companies -  Roche, Regeneron, Adverum Biotechnologies, and Iconic Therapeutics
Delveinsight Business Research LLP
DelveInsight’s “Choroidal Neovascularization Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Choroidal Neovascularization Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Choroidal Neovascularization market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Choroidal Neovascularization Market

Choroidal Neovascularization: An Overview

Choroidal neovascularization (CNV) involves the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the subretinal pigment epithelium (sub-RPE) or subretinal space. CNV is a major cause of visual loss. The symptoms of CNV include distortion or waviness of central vision or a grey/black/void spot in the central vision.

As per DelveInsight, the Choroidal Neovascularization Market Size is anticipated to increase during the study period owing to the rise in the number of incident population in the 7MM. Along with these the extensive research and development activities of pharmaceutical companies for developing the therapies for Choroidal Neovascularization will also significantly impact the market.

Choroidal Neovascularization Market Key Facts

  • As per the study conducted by Jeffrey R.Willis et al. (2016), there was a population burden of 41, 111 adults with myopic CNV in the United States in 2014.

  • As per the study conducted by Wong TY et al. (2014), the Incidence of CNV in individuals with pathologic myopia was reported to be 5.2%-11.3%, and was bilateral in approximately 15% of patients. 

  • As per the “National Institute For Health And Care Excellence”, in England, it has been estimated that over 300,000 people have pathological myopia and that the incident population of myopic CNV is 3200. Approximately 35% of people who develop CNV in one eye will develop it in the other eye within 8 years.

Choroidal Neovascularization Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Choroidal Neovascularization market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Choroidal Neovascularization market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Choroidal Neovascularization Epidemiology

The epidemiology section covers insights into the historical and current Choroidal Neovascularization patient pool and forecasted trends for every seven major countries (7MM)  from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool, future trends, and assumptions undertaken.

Choroidal Neovascularization Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Choroidal Neovascularization market or expected to get launched during the study period. The analysis covers Choroidal Neovascularization market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Choroidal Neovascularization Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report –

Choroidal Neovascularization Therapeutics Analysis

The Choroidal Neovascularization market dynamics is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and also expects the launch of emerging therapies.

Some of the key companies in the Choroidal Neovascularization Market include:

  • Roche

  • Regeneron Pharmaceuticals

  • Adverum Biotechnologies

  • Iconic Therapeutics

And many others.

Choroidal Neovascularization Therapies covered in the report include:

  • Lucentis 

  • Eylea

  • ADVM-022

  • ICON-1

And many more.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Choroidal Neovascularization Competitive Intelligence Analysis

4. Choroidal Neovascularization Market Overview at a Glance

5. Choroidal Neovascularization Disease Background and Overview

6. Choroidal Neovascularization Patient Journey

7. Choroidal Neovascularization Epidemiology and Patient Population

8. Choroidal Neovascularization Treatment Algorithm, Current Treatment, and Medical Practices

9. Choroidal Neovascularization Unmet Needs

10. Key Endpoints of Choroidal Neovascularization Treatment

11. Choroidal Neovascularization Marketed Products

12. Choroidal Neovascularization Emerging Therapies

13. Choroidal Neovascularization Seven Major Market Analysis

14. Attribute Analysis

15. Choroidal Neovascularization Market Outlook (7 major markets)

16. Choroidal Neovascularization Access and Reimbursement Overview

17. KOL Views on the Choroidal Neovascularization Market.

18. Choroidal Neovascularization Market Drivers

19. Choroidal Neovascularization Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Other Latest Reports By DelveInsight

West Nile Encephalitis Market

DelveInsight’s “West Nile Encephalitis Market” report delivers an in-depth understanding of the historical and forecasted epidemiology, the West Nile Encephalitis market size, shares, and trends analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan) as well as the emerging therapies and key companies in the therapeutic domain.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States